Zevra Therapeutics Publishes Four-Year MIPLYFFA Real-World NPC Data
BOSTON, Aug. 3, 2026 Zevra Therapeutics, Inc. announced the publication of four-year real-world safety and effectiveness data evaluating MIPLYFFA®...
antibody-drug conjugate
Advertisement
Rocket Pharmaceuticals Reports Positive RP-A501 Safety Update
CRANBURY, N.J., Aug. 3, 2026 Rocket Pharmaceuticals, Inc. announced a positive clinical safety update from the first three patients...
Aravax Wins FDA Fast Track Designation for PVX108
MELBOURNE, Australia & OXFORD, UK, Aug. 3, 2026 Aravax announced that the U.S. Food and Drug Administration (FDA) has...
Kelun-Biotech Advances First Dual-Payload ADC into Clinical Trials
CHENGDU, China, July 27, 2026 Kelun-Biotech has announced that the Center for Drug Evaluation (CDE) of China’s National Medical...
Innate Pharma Reaches Phase 1 Enrollment Milestone for IPH4502
Marseille, France | July 21, 2026 Innate Pharma SA has announced the completion of enrollment in the dose-escalation portion...
Advertisements
CU Anschutz Study Raises GLP-1 Compounding Concerns
AURORA, Colo., July 17, 2026 Researchers at the University of Colorado Anschutz Medical Campus have reported that the market...
SOTIO Wins FDA Fast Track for Advanced CRC
PRAGUE, Basel & BOSTON, July 14, 2026 SOTIO Biotech announced that the U.S. Food and Drug Administration (FDA) has...
LEO Pharma Reports Positive Phase 2 Tralokinumab Results
BALLERUP, Denmark, July 9, 2026 LEO Pharma A/S has announced positive results from the Phase 2 TRAPEDS-1 clinical trial...
Immunome NDA for Varegacestat Accepted by FDA for DTs
BOTHELL, Wash., July 8, 2026 Immunome, Inc. has announced that the U.S. Food and Drug Administration (FDA) has accepted...
SK pharmteco Partners With OTXL to Advance Rare Therapies
RANCHO CORDOVA, Calif., June 18, 2026 SK pharmteco, a leading global contract development and manufacturing organization (CDMO), has announced...
Advertisement
